• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心动过速性心肌病:心力衰竭的机制及临床意义

Tachycardia-induced cardiomyopathy: mechanisms of heart failure and clinical implications.

作者信息

Calò Leonardo, De Ruvo Ermenegildo, Sette Antonella, Sciarra Luigi, Scioli Roberto, Sebastiani Francesco, Topai Marco, Iulianella Renzo, Navone Giovanna, Lioy Ernesto, Gaita Fiorenzo

机构信息

Division of Cardiology, Policlinico Casilino, ASL RM/B Rome, Italy.

出版信息

J Cardiovasc Med (Hagerstown). 2007 Mar;8(3):138-43. doi: 10.2459/01.JCM.0000260841.30415.62.

DOI:10.2459/01.JCM.0000260841.30415.62
PMID:17312430
Abstract

The prognosis of dilated cardiomyopathy is generally poor. The cause of ventricular dysfunction often cannot be identified. In most cases, the clinical history of cardiomyopathy is irreversible but, in some cases, potentially curable causes may be identified. The development of cardiomyopathy may be correlated to atrial or to ventricular arrhythmias. In this scenario, atrial fibrillation is the most frequent cause of ventricular dysfunction, even if it may also be secondary to heart failure. The diagnosis of tachycardia-induced cardiomyopathy can be made only after the improvement of the left ventricular function once the cardiac frequency has slowed down.

摘要

扩张型心肌病的预后通常较差。心室功能障碍的病因往往难以确定。在大多数情况下,心肌病的临床病程是不可逆的,但在某些情况下,可能会发现潜在的可治愈病因。心肌病的发展可能与房性或室性心律失常相关。在这种情况下,心房颤动是心室功能障碍最常见的原因,即使它也可能继发于心力衰竭。只有在心率减慢后左心室功能改善时,才能做出心动过速性心肌病的诊断。

相似文献

1
Tachycardia-induced cardiomyopathy: mechanisms of heart failure and clinical implications.心动过速性心肌病:心力衰竭的机制及临床意义
J Cardiovasc Med (Hagerstown). 2007 Mar;8(3):138-43. doi: 10.2459/01.JCM.0000260841.30415.62.
2
[Arrhythmia-induced dilated cardiomyopathies].[心律失常性扩张型心肌病]
Bull Acad Natl Med. 2006 Jun;190(6):1225-35; discussion 1235-6.
3
Tachycardia mediated cardiomyopathy: pathophysiology, mechanisms, clinical features and management.心动过速性心肌病:病理生理学、机制、临床特征和治疗。
Int J Cardiol. 2014 Mar 1;172(1):40-6. doi: 10.1016/j.ijcard.2013.12.180. Epub 2014 Jan 8.
4
Tachycardia-induced cardiomyopathy.心动过速性心肌病
Am J Med. 2003 Jan;114(1):51-5. doi: 10.1016/s0002-9343(02)01472-9.
5
Reversible symptomatic dilated cardiomyopathy in older children and young adolescents due to primary non-sinus supraventricular tachyarrhythmias.原发性非窦性室上性快速心律失常所致大龄儿童和青少年可逆性症状性扩张型心肌病。
Pediatr Cardiol. 2003 May-Jun;24(3):274-9. doi: 10.1007/s00246-002-0274-5. Epub 2003 Jan 28.
6
Tachycardiomyopathies.
Rev Port Cardiol. 2002 May;21(5):585-92.
7
The pig as a model of tachycardia and dilated cardiomyopathy.
Lab Anim Sci. 1990 Sep;40(5):495-501.
8
[Arrhythmogenic effects of alcohol].[酒精的致心律失常作用]
Rev Med Chir Soc Med Nat Iasi. 2011 Oct-Dec;115(4):1052-6.
9
Tachycardiomyopathy: mechanisms and clinical implications.
Pacing Clin Electrophysiol. 1996 Jan;19(1):95-106. doi: 10.1111/j.1540-8159.1996.tb04796.x.
10
[Recurrent rhythmic cardiomyopathy secondary to idiopathic ventricular tachycardia].
Arch Mal Coeur Vaiss. 2001 Jun;94(6):617-21.

引用本文的文献

1
Atrial fibrillation ablation: The key ingredient for managing arrhythmia-induced cardiomyopathy.心房颤动消融术:治疗心律失常性心肌病的关键要素。
HeartRhythm Case Rep. 2024 Nov 15;10(11):773-774. doi: 10.1016/j.hrcr.2024.08.030. eCollection 2024 Nov.
2
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2023 ACC/AHA/ACCP/HRS 指南:心房颤动的诊断与管理——美国心脏病学会/美国心脏协会联合临床实践指南委员会的报告。
J Am Coll Cardiol. 2024 Jan 2;83(1):109-279. doi: 10.1016/j.jacc.2023.08.017. Epub 2023 Nov 30.
3
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
2023 ACC/AHA/ACCP/HRS 指南:心房颤动的诊断与管理——美国心脏病学会/美国心脏协会联合临床实践指南委员会的报告。
Circulation. 2024 Jan 2;149(1):e1-e156. doi: 10.1161/CIR.0000000000001193. Epub 2023 Nov 30.
4
Integration of proteomic and metabolomic characterization in atrial fibrillation-induced heart failure.蛋白质组学和代谢组学特征在心房颤动引起的心力衰竭中的整合。
BMC Genomics. 2022 Dec 1;23(1):789. doi: 10.1186/s12864-022-09044-z.
5
Treatment-Resistant Wide-Complex Tachycardia in a Three-Year-Old Girl.一名三岁女童的难治性宽QRS波心动过速
Cureus. 2022 Jan 28;14(1):e21683. doi: 10.7759/cureus.21683. eCollection 2022 Jan.
6
Beta-blocker treatment in heart failure patients with atrial fibrillation: challenges and perspectives.心力衰竭合并心房颤动患者的β受体阻滞剂治疗:挑战与展望。
J Geriatr Cardiol. 2021 May 28;18(5):362-375. doi: 10.11909/j.issn.1671-5411.2021.05.008.
7
Management of tachyarrhythmias in pregnancy - A review.妊娠期快速性心律失常的管理——综述
Obstet Med. 2020 Dec;13(4):159-173. doi: 10.1177/1753495X20913448. Epub 2020 Apr 20.
8
Atrioventricular accessory pathways in 89 dogs: Clinical features and outcome after radiofrequency catheter ablation.89只犬的房室旁道:射频导管消融后的临床特征及结果
J Vet Intern Med. 2018 Sep;32(5):1517-1529. doi: 10.1111/jvim.15248. Epub 2018 Sep 14.
9
Arrhythmia induced cardiomyopathy.心律失常性心肌病
J Arrhythm. 2018 Jul 20;34(4):376-383. doi: 10.1002/joa3.12094. eCollection 2018 Aug.
10
Should Ablation Be First-Line Therapy for Patients with Paroxysmal AF?对于阵发性房颤患者,消融术应作为一线治疗方法吗?
Curr Treat Options Cardiovasc Med. 2017 May;19(5):38. doi: 10.1007/s11936-017-0537-3.